Tyrosine-kinase inhibitors in the treatment of non-small cell lung cancer in usual clinical practice

被引：0
|
作者：
Caparros Romero, S. [1 ]
Ruiz Fuentes, S. [1 ]
机构：
[1] Hosp Axarquia, Pharm, Malaga, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2022年 / 44卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PP176
引用
收藏
页码：1553 / 1553
页数：1
相关论文
共 50 条
  • [1] Tyrosine-kinase inhibitors for non-small cell lung cancer - addition - EML
    SELECTION AND USE OF ESSENTIAL MEDICINES: REPORT OF THE WHO EXPERT COMMITTEE ON SELECTION AND USE OF ESSENTIAL MEDICINES, 2019 (INCLUDING THE 21ST WHO MODEL LIST OF ESSENTIAL MEDICINES AND THE 7TH WHO MODEL LIST OF ESSENTIAL MEDICINES FOR CHILDREN), 2019, 1021 : 293 - 301
  • [2] EGFR tyrosine kinase inhibitors in the treatment of advanced non-small cell lung cancer
    Kowalski, D. M.
    Krzakowski, M.
    Jaskiewicz, P.
    Janowicz-Zebrowska, A.
    Glogowski, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Emerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Fujino, Toshio
    Suda, Kenichi
    Mitsudomi, Tetsuya
    EXPERT OPINION ON EMERGING DRUGS, 2020, 25 (03) : 229 - 249
  • [4] The role of EGFR tyrosine kinase inhibitors in the treatment of non-small cell lung cancer
    Kowalczyk, Anna
    Szutowicz-Zielinska, Ewa
    Dziadziuszko, Rafal
    Jassem, Jacek
    ONCOLOGY IN CLINICAL PRACTICE, 2005, 1 (04): : 217 - 224
  • [5] Tyrosine kinase inhibitors with antiangiogenic properties for the treatment of non-small cell lung cancer
    Nguewa, Paul A.
    Calvo, Alfonso
    Pullamsetti, Soni Savai
    Banat, Gamal Andre
    Grimminger, Friedrich
    Savai, Rajkumar
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (01) : 61 - 74
  • [6] Tyrosine kinase inhibitors in the management of non-small cell lung cancer
    Perol, M.
    Arpin, D.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S188 - S197
  • [7] Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer
    Vavala, Tiziana
    Mariniello, Annapaola
    Novello, Silvia
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S48 - S54
  • [8] Neoadjuvant treatment with tyrosine kinase inhibitors in patients with resectable non-small cell lung cancer
    Franco, Fernando
    Provencio, Mariano
    JOURNAL OF THORACIC DISEASE, 2019, 11 (10) : 4092 - 4095
  • [9] Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
    Scagliotti, Giorgio
    Govindan, Ramaswamy
    ONCOLOGIST, 2010, 15 (05): : 436 - 446
  • [10] Clinical and molecular predictors of response to EGFR tyrosine kinase inhibitors in non-small cell lung cancer
    Rouge, Thibault de La Motte
    Valent, Alexander
    Ambrosetti, Damien
    Vielh, Philippe
    Lacroix, Ludovic
    ANNALES DE PATHOLOGIE, 2007, 27 (05) : 353 - 363
12345